Professional support to address regulatory observations in the UK. Expert regulatory review, corrective action planning, and compliance guidance to streamline audit readiness and resolve MHRA observations.Addressing regulatory observations in the UK is a specialised support service for pharmaceutical and life sciences companies facing scrutiny from regulatory inspections, including MHRA audits and adverse findings such as 483 reports.